Latest Articles
Staying Silent Can Leave You at Risk for Endometrial Cancer - Southwest Voices
Staying Silent Can Leave You at Risk for Endometrial Cancer Southwest Voices
Published: June 1, 2026, 3:01 p.m.
Staying Silent Can Leave You at Risk for Endometrial Cancer - presspublications.com
Staying Silent Can Leave You at Risk for Endometrial Cancer presspublications.com
Published: June 1, 2026, 3:01 p.m.
Analysis of Tumor-Associated Macrophages (TAM) Using Cluster of Differentiation 68 (CD68) Immunohistochemical Marker in Endometrial Carcinoma - Cureus
Analysis of Tumor-Associated Macrophages (TAM) Using Cluster of Differentiation 68 (CD68) Immunohistochemical Marker in Endometrial Carcinoma Cureus
Published: May 31, 2026, 4:44 p.m.
Merck's ADC candidate meets goals in endometrial cancer study - MSN
Merck's ADC candidate meets goals in endometrial cancer study MSN
Published: May 31, 2026, 5:59 a.m.
Puxitatug Samrotecan Elicits High Response Rate in Select Endometrial Cancers - OncLive
Puxitatug Samrotecan Elicits High Response Rate in Select Endometrial Cancers OncLive
Published: May 30, 2026, 9:59 p.m.
Endometrial Cancer Survivors Face Harder Path to IVF Success - MedPage Today
Endometrial Cancer Survivors Face Harder Path to IVF Success MedPage Today
Published: May 30, 2026, 4:38 p.m.
Dostarlimab Plus Chemo May Offer Cure to Some Advanced Endometrial Cancer Patients - Cancer Therapy Advisor
Dostarlimab Plus Chemo May Offer Cure to Some Advanced Endometrial Cancer Patients Cancer Therapy Advisor
Published: May 30, 2026, 4 a.m.
Pembrolizumab combination therapy improves survival in recurrent endometrial cancer patients - News-Medical
Pembrolizumab combination therapy improves survival in recurrent endometrial cancer patients News-Medical
Published: May 30, 2026, 2:16 a.m.
Long-Term RUBY Data Show Potential for Curative Intent With Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer - OncLive
Long-Term RUBY Data Show Potential for Curative Intent With Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer OncLive
Published: May 30, 2026, 12:24 a.m.
Contributions of T-helper 9 cells in endometriosis-associated inflammation and lesion growth.
Endometriosis is an inflammatory gynecologic disease characterized by ectopic growth of endometrial-like tissue, resulting in pelvic pain and infertility. T-helper 9 (Th9) cells play a known role in various chronic …
Published: May 30, 2026, midnight
Link copied to clipboard!